These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 27577529

  • 1. Suramin treatment reduces chikungunya pathogenesis in mice.
    Kuo SC, Wang YM, Ho YJ, Chang TY, Lai ZZ, Tsui PY, Wu TY, Lin CC.
    Antiviral Res; 2016 Oct; 134():89-96. PubMed ID: 27577529
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effects of combination treatment using EGCG and suramin against the chikungunya virus.
    Lu JW, Hsieh PS, Lin CC, Hu MK, Huang SM, Wang YM, Liang CY, Gong Z, Ho YJ.
    Biochem Biophys Res Commun; 2017 Sep 23; 491(3):595-602. PubMed ID: 28760340
    [Abstract] [Full Text] [Related]

  • 3. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.
    Henß L, Beck S, Weidner T, Biedenkopf N, Sliva K, Weber C, Becker S, Schnierle BS.
    Virol J; 2016 Aug 31; 13(1):149. PubMed ID: 27581733
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication.
    Ferreira AC, Reis PA, de Freitas CS, Sacramento CQ, Villas Bôas Hoelz L, Bastos MM, Mattos M, Rocha N, Gomes de Azevedo Quintanilha I, da Silva Gouveia Pedrosa C, Rocha Quintino Souza L, Correia Loiola E, Trindade P, Rangel Vieira Y, Barbosa-Lima G, de Castro Faria Neto HC, Boechat N, Rehen SK, Brüning K, Bozza FA, Bozza PT, Souza TML.
    Antimicrob Agents Chemother; 2019 Feb 31; 63(2):. PubMed ID: 30455237
    [Abstract] [Full Text] [Related]

  • 7. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
    Rothan HA, Bahrani H, Abdulrahman AY, Mohamed Z, Teoh TC, Othman S, Rashid NN, Rahman NA, Yusof R.
    Antiviral Res; 2016 Mar 31; 127():50-6. PubMed ID: 26794398
    [Abstract] [Full Text] [Related]

  • 8. Suramin inhibits chikungunya virus replication through multiple mechanisms.
    Albulescu IC, van Hoolwerff M, Wolters LA, Bottaro E, Nastruzzi C, Yang SC, Tsay SC, Hwu JR, Snijder EJ, van Hemert MJ.
    Antiviral Res; 2015 Sep 31; 121():39-46. PubMed ID: 26112648
    [Abstract] [Full Text] [Related]

  • 9. Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection.
    Abdelnabi R, Jochmans D, Verbeken E, Neyts J, Delang L.
    Antiviral Res; 2018 Jan 31; 149():113-117. PubMed ID: 28958920
    [Abstract] [Full Text] [Related]

  • 10. Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection.
    Albulescu IC, White-Scholten L, Tas A, Hoornweg TE, Ferla S, Kovacikova K, Smit JM, Brancale A, Snijder EJ, van Hemert MJ.
    Viruses; 2020 Mar 17; 12(3):. PubMed ID: 32191995
    [Abstract] [Full Text] [Related]

  • 11. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
    Varghese FS, Thaa B, Amrun SN, Simarmata D, Rausalu K, Nyman TA, Merits A, McInerney GM, Ng LFP, Ahola T.
    J Virol; 2016 Nov 01; 90(21):9743-9757. PubMed ID: 27535052
    [Abstract] [Full Text] [Related]

  • 12. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW, Lentscher AJ, Zamora PF, Silva LA, May NA, Bauer JA, Morrison TE, Dermody TS.
    mBio; 2016 May 24; 7(3):. PubMed ID: 27222471
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of a peptide-fusion protein (Latarcin-PAP1-Thanatin) against chikungunya virus.
    Rothan HA, Bahrani H, Shankar EM, Rahman NA, Yusof R.
    Antiviral Res; 2014 Aug 24; 108():173-80. PubMed ID: 24929084
    [Abstract] [Full Text] [Related]

  • 14. Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review.
    Lo Presti A, Cella E, Angeletti S, Ciccozzi M.
    Infect Genet Evol; 2016 Jul 24; 41():270-278. PubMed ID: 27085290
    [Abstract] [Full Text] [Related]

  • 15. Antiviral activity of stearylamine against chikungunya virus.
    Jeengar MK, Kurakula M, Patil P, More A, Sistla R, Parashar D.
    Chem Phys Lipids; 2021 Mar 24; 235():105049. PubMed ID: 33422549
    [Abstract] [Full Text] [Related]

  • 16. Pentosan Polysulfate: a Novel Glycosaminoglycan-Like Molecule for Effective Treatment of Alphavirus-Induced Cartilage Destruction and Inflammatory Disease.
    Herrero LJ, Foo SS, Sheng KC, Chen W, Forwood MR, Bucala R, Mahalingam S.
    J Virol; 2015 Aug 24; 89(15):8063-76. PubMed ID: 26018160
    [Abstract] [Full Text] [Related]

  • 17. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
    Varghese FS, Kaukinen P, Gläsker S, Bespalov M, Hanski L, Wennerberg K, Kümmerer BM, Ahola T.
    Antiviral Res; 2016 Feb 24; 126():117-24. PubMed ID: 26752081
    [Abstract] [Full Text] [Related]

  • 18. Activity of andrographolide against chikungunya virus infection.
    Wintachai P, Kaur P, Lee RC, Ramphan S, Kuadkitkan A, Wikan N, Ubol S, Roytrakul S, Chu JJ, Smith DR.
    Sci Rep; 2015 Sep 18; 5():14179. PubMed ID: 26384169
    [Abstract] [Full Text] [Related]

  • 19. Chikungunya virus infections: time to act, time to treat.
    Abdelnabi R, Neyts J, Delang L.
    Curr Opin Virol; 2017 Jun 18; 24():25-30. PubMed ID: 28414993
    [Abstract] [Full Text] [Related]

  • 20. Nifuroxazide Prevents Chikungunya Virus Infection Both In Vitro and In Vivo via Suppressing Viral Replication.
    Liu Y, Xu M, Xia B, Qiao Z, He Y, Liu Y, Pan Z, Zhang C, Peng H, Liang X, Zhao P, Tang H, Zheng X.
    Viruses; 2024 Aug 19; 16(8):. PubMed ID: 39205296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.